Industry e-symposium: Multidisciplinary approach in aHUS diagnosis

This webinar will explore the importance of a multidisciplinary approach in the diagnosis of atypical hemolytic uremic syndrome (aHUS). The topic emphasizes how different specialties can collaborate effectively, even in settings without formalized teams, to improve diagnostic outcomes.

Learning objectives: 

• Understanding Collaboration: Discover how different specialties can work together to enhance the diagnosis of atypical Hemolytic Uremic Syndrome (aHUS), even without formal multidisciplinary teams.
• Practical Strategies: Learn actionable approaches for integrating diverse expertise in clinical settings to improve diagnostic accuracy.
• Focus on Resource-Constrained Settings: Gain insights into tailored diagnostic solutions that address unique challenges in healthcare environments with varying resource availability.
• Improved Outcomes: Understand how a multidisciplinary approach can lead to faster and more accurate aHUS diagnoses, ultimately benefiting patient care.
• Cross-Specialty Communication: Explore methods to foster effective communication and coordination among healthcare professionals from various fields.
• Adaptable Frameworks: Acquire knowledge of flexible frameworks for collaboration that can be applied in different settings.

Further reading:

• Uriol Rivera, Miguel G et al. “Impact of a multidisciplinary team for the management of thrombotic microangiopathy.” PloS one vol. 13,11 e0206558. 2 Nov. 2018, doi:10.1371/journal.pone.0206558
• Nguyen, Matthew et al. “Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomes.” BMC nephrology 26,1 537. 26 Sep. 2025, doi:10.1186/s12882-025-04446-z
• Gordon, Craig E., et al. “Thrombotic microangiopathy: a multidisciplinary team approach.” American Journal of Kidney Diseases5 (2017): 715-721.
• Uriol-Rivera, Miguel G et al. “PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database.” BMC nephrology 26,1 241. 15 May. 2025, doi:10.1186/s12882-025-04156-6
• Yerigeri, Keval, et al. “Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management.” Journal of multidisciplinary healthcare (2023): 2233-2249.
• Bogdan et al., Atypical Hemolytic Uremic Syndrome: A Review of Complement Dysregulation, Genetic Susceptibility and Multiorgan Involvement J. Clin. Med. 2025, 14(7), 2527;

This is an industry e-symposium organized by Alexion, AstraZeneca Rare Disease.